The Indian pharmaceutical industry is the 3rd largest in the world by volume and 14th by value, with a market size of
over USD 50 billion in 2023. It is expected to reach USD 130 billion by 2030, driven by robust demand, export growth.
The Indian government is proactively fostering the sector with initiatives such as the Production Linked Incentive (PLI) Scheme, which focuses on boosting domestic manufacturing. Additionally, there are programs aimed at promoting parks for bulk drugs and medical devices.
India is the world’s leading supplier of generic drugs, accounting for more than 20% of the global volume of generic medicines. Furthermore, the country meets 50% of the global demand for vaccines, underscoring its vital contribution to global healthcare.
Growth in the sector is fueled by several factors, including increased healthcare spending, rising income levels, better access to healthcare, and an aging population. Additionally, the digital transformation in healthcare delivery is enhancing the pharmaceutical supply chain, further benefiting the industry.
Maximizing Government Scheme Benefits for Sanitary Pad Production & Supply